Axsome Therapeutics, Inc. (AXSM)
NASDAQ·Healthcare·Biotechnology
$193.56
-4.70%
Mkt Cap $10.69B
Analyst Ratings
Buy
23
Hold
2
Sell
0
Price Target (79 analysts)
$282.53
Range $246.00 – $380.00
Implied Upside
+46.0%
Consensus $282.53 vs current $193.56